Company Search:
Advanced Search
Sponsored Links
Takeda Pharmaceutical Company Limited - ADR Company Snapshot
Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other companies in this sector in the United States: CSL Limited (2019 sales of $8.54 billion of which 84% was CSL Behring), Daiichi Sankyo Company Limited ($8.38 billion of which 93% was Prescription drugs), and Eisai Company Limited ($5.79 billion of which 88% was Pharmaceutical Business).

Sales Analysis. Takeda Pharmaceutical Company Limited reported sales of $18.90 billion for the fiscal year ending March of 2019. This represents an increase of 18.1% versus 2018, when the company's sales were $16.01 billion. Sales of Pharmaceutical Business saw an increase of 19.2% in 2019, from $15.31 billion to $18.26 billion. Not all segments of Takeda Pharmaceutical Company Limited experienced an increase in sales in 2019: sales of Intellectual Property and Service Revenu fell 7.8% to $639.27 million. (However, this segment's sales were only a very small portion of the company's overall sales).
  Stock Performance Chart for Takeda Pharmaceutical Company Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 20.30
(Figures in U.S. Dollars)
1 Week -0.4%   13 Weeks 8.8%  
4 Weeks 20.4%   52 Weeks 8.0%  
Takeda Pharmaceutical Company Limited - ADR Key Data:
  Ticker: TAK Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 18,895,988,240
(Year Ending Jan 2020).
Employees: 49,578
  Currency: U.S. Dollars Market Cap: 63,244,512,853
  Fiscal Yr Ends: March Shares Outstanding: 3,115,493,244
  Share Type: Common Closely Held Shares: 41,641,324
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.